Clinical trial
Studies of AQ-13, a Candidate Aminoquinoline Antimalarial, in Comparison With…
NCT00323375 · Tulane University Health Sciences Center, Other · Completed
Key facts
| NCT number | NCT00323375 |
|---|---|
| Title | Studies of AQ-13, a Candidate Aminoquinoline Antimalarial, in Comparison With Chloroquine |
| Official title | Randomized Controlled Trial of AQ-13, a Candidate Aminoquinoline Antimalarial, in Comparison With Chloroquine |
| Lead sponsor | Tulane University Health Sciences Center, Other |
| Collaborators | National Institute of Allergy and Infectious Diseases (NIAID) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Malaria |
| Intervention type | Drug |
| Interventions | AQ-13, Chloroquine (CQ) Treatment |
| Enrollment | 122 |
| Start date | Aug 1, 1999 |
| Primary completion | Jun 30, 2005 |
| Completion | Aug 31, 2005 |
| First posted | May 9, 2006 |
| Last update posted | Dec 8, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: